Category IP-Watch Briefs

EU Launches Consultation On Investor-State Dispute Mechanism In TTIP

European Union Trade Commissioner Karel de Gucht today announced a three-month public consultation on investor-state dispute settlement (ISDS) mechanisms in the Transatlantic Trade and Investment Partnership.

New QUNO Reports Encourage Plant Variety Protection Alternatives

The Quaker UN Office in Geneva has announced two new publications on intellectual property, agriculture, food and biological diversity.

Successful WHO Drug Prequalification Programme Deemed At Risk

A 12-year-old World Health Organization programme for prequalifying medical products has helped international organisations and others to safely purchase billions of US dollars' worth of quality medicines per year, but now is at risk due to funding shortages, a new study released today found.

Event: The 6th Annual Corporate IP Counsel Forum

March 19-20, 2014 – Affinia Manhattan – New York City – www.worldcongress.com/corporateIP

Optimize your IP portfolio. In this cross-industry event, the most timely and critical issues will be discussed and analyzed by senior counsel from Bank of America, General Mills, Honeywell, IBM, MLB Advanced Media, MasterCard, S.C. Johnson, and more; providing insight and strategies to help you tackle the latest challenges in IP.

IP-Watch Reader Discount: when reserving your seat, use promo code IPW200 to take $200.00 off the current registration fee.

New EU Customs Enforcement Regulation On IPRs Takes Effect

A new regulation on the enforcement of intellectual property rights took effect in the European Union on 1 January, strengthening enforcement and extending the range of rights protected, according to a legal analysis.

New SIPO Commissioner Meets With Top WIPO Official From China

The State Intellectual Property Office of China (SIPO) has a new commissioner, Shen Changyu. And the World Intellectual Property Organization wasted no time in meeting with him. China was approved last month to receive a new WIPO office.

Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India

An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally.

CPhI's 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies.

The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets.

The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries.

Click here to view the region-wise agenda.

Free download for IP-Watch Readers! Click here to view presentations from 2013!